Follow-The-Filings

ALZN Alzamend Neuro

Alzamend Neuro earnings company data as of 7:39 PM ET 9/17

Scheduled

1 period · newest first · EPS & Rev stacked · nothing reported yet

Period Date Metric Estimate Actual Result
FY2026 Q3 10 Sep EPS -0.56 — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR · 20 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,9.01
10-Q Period Jul 31, 2026
S-1 —
8-K 1.01,3.01,3.02,5.03,9.01
10-K Period Apr 30, 2026
8-K 8.01,9.01
8-K 5.07,9.01
8-K 3.01,9.01
10-Q Period Jan 31, 2026
8-K 1.01,9.01
424B5 —
DEFA14A —
10-Q Period Oct 31, 2025
8-K 8.01,9.01
8-K 5.03,9.01
8-K 3.02,9.01
8-K 3.02,9.01
10-Q Period Jul 31, 2025
8-K 3.02,9.01
8-K 2.02,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 4 rows shown

Filed Form Detail Links
4/A Period Apr 14, 2026 · 2 forms
4 Period Aug 26, 2026
4/A Period Jul 31, 2026
4 Period Jul 31, 2026

15 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice